
Recreational Cannabis vs. Medical Cannabis Sales in Canada
Under the Cannabis Act and Cannabis Regulations, businesses (small and large) can sell cannabis both recreationally and to medical patients in Canada. However, there are
Back on August 24, 2016, the ACMPR replaced the 2013 implementation of the MMPR. The Supreme Court of Canada ruled that restricting legal access to only dried marijuana was unconstitutional. The Court decided that individuals with medical needs have the right to use and make other cannabis products. As a result, the Minister of Health issued exemptions to allow licensed producers to cultivate and sell cannabis oil, fresh marijuana buds, and leaves in addition to dried marijuana. The regulations also allowed authorized users to possess and alter different forms of cannabis.
Under the Cannabis Act, Health Canada established a national Cannabis Tracking System, also known as the Cannabis Tracking and Licensing System (CTLS). The system was enacted in order to track high-level movements of cannabis and prevent supply chain diversion and/or inversion. It is also the system applicants should use to apply for a cannabis license.
Health Canada has established that the CTLS be the primary way to submit application for cannabis licensing. The first step in creating an application is to set up an individual user account. As a reference for more information, the CTLS “Getting Startted Guide” is available on the Health Canada website. If it is not feasible to use CTLS as the primary manner for licensing, contact Health Canada for more guidance.
Under the Cannabis Act and Cannabis Regulations, businesses (small and large) can sell cannabis both recreationally and to medical patients in Canada. However, there are
What is the importance of Social Equity? These days, a flood of new states have pushed forward with some type of cannabis legislation, with 37+
The U.S. Hemp Industry Opportunity in Europe The industrial hemp industry in North America has been emerging ever since the 2018 Farm Bill was passed
In April 2022, The House of Representatives approved a bipartisan marijuana research bill that will provide a streamlined process for studying the medical benefits of
Subscribe To Our Newsletter